Executive Committee: HBM Healthcare Investments AG

Manager
Positions heldSince
Andreas Wicki

Andreas Wicki

66 year

Chief Executive Officer 2012-02-19
Erwin Troxler

Erwin Troxler

55 year

Director of Finance/CFO 2011-10-31
Benedikt Suter

Benedikt Suter

61 year

Corporate Secretary -

Composition of the Board of Directors: HBM Healthcare Investments AG

Director
CommitteesSince
Hans-Peter Hasler

Hans-Peter Hasler

69 year

Audit Committee 2021-02-28
Compensation Committee
Governance Committee
Nominating Committee 2017-12-12
Nominating Committee Chair 2021-02-28
Governance Committee Chair 2021-02-28
Elaine Jones

Elaine Jones

70 year

Audit Committee 2015-11-30
Governance Committee Chair 2015-11-30
Nominating Committee Chair 2015-11-30
Compensation Committee
Governance Committee 2019-04-30
Nominating Committee 2019-04-30
Mark Kronenfeld

Mark Kronenfeld

70 year

Compensation Committee 2013-09-12
Governance Committee Chair 2013-06-11
Nominating Committee Chair 2013-06-11
Rudolf Lanz

Rudolf Lanz

75 year

Audit Committee 2012-02-19
Nominating Committee 2012-02-19
Mario Giuliani

Mario Giuliani

53 year

Director/Board Member 2011-12-31
Stella Xu

Stella Xu

54 year

Director/Board Member 2020-05-31

Former Officers and Directors: HBM Healthcare Investments AG

Insider
Positions held
SinceUntil
Heinz Riesenhuber
Heinz Riesenhuber
Director/Board Member 2000-12-31 2021-06-17
Eduard Enrico Holdener
Eduard Enrico Holdener
Director/Board Member 2007-12-31 2021-06-17
Robert Alexander Ingram
Robert Alexander Ingram
Director/Board Member 2005-12-31 2021-06-17
Erich Maximilian Platzer
Erich Maximilian Platzer
Founder 2000-12-31 -
Gary T. Shearman
Gary T. Shearman
Corporate Officer/Principal - -
Daniel Richner
Daniel Richner
Corporate Officer/Principal - -

Age distribution of managers

Parity Men Women

Male9
Female0

Of which Executive Committee

Male3
Female0

Of which Directors

Male6
Female0
Logo HBM Healthcare Investments AG
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Employees
700
More about the company